CEO, Dr Tim Oldham interviewed by Pitt Street Research
Read MoreNews & Media – old
CEO Dr Tim Oldham speaks about i-body development in Insights Care
Read MoreArticle by CSO Mick Foley on next-generation antibody like therapeutics published in EBR
Read MoreFlexible formatting of AdAlta’s i-body technology
Read MoreA flurry of deals demonstrates the significant pharma interest in IPF
Read MoreAusBiotech Case Study: Scarred for life
Read MoreCEO Sam Cobb updates the Morgans Network
Read MoreCEO Sam Cobb in discussion with Proactive Investors
Read More
